Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
lifespin
Regensburg, Bavaria, Germanylifespin.health ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Lifespin has launched its first commercial diagnostic product—the Lifespin™ Amino Acid Profiler—using its proprietary AI-driven NMR metabolomics platform. The company’s technology enables deep metabolic profiling from small blood samples to support early diagnosis and monitoring across a range of conditions. Clinical validation includes proven performance against legacy clinical chemistry methods. Additional panels/tests are in the pipeline targeting neurological diseases (e.g., multiple sclerosis), cancers, drug monitoring, and population health management.
- Therapeutic areas
- OncologyMetabolic DisordersNeurologyOther
- Modalities
- Device (NMR-based diagnostics platform)Software (AI-driven analytics)Non-pharmacological therapy (diagnostics only; not therapeutics)
- Industry
- Metabolite Diagnostics
02
Partnerships
Leipzig Research Center for Civilization Diseases (“LIFE”)Charité Hospital BerlinWyss Diagnostics Accelerator at Harvard Universitypartnerships with ~20 hospital partners across Europe for clinical studies
Beyond the preview
Go deeper on lifespin.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on lifespin.